about
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levelsA targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolismMutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemiaConformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopyCETP Inhibition: Past Failures and Future HopesThe role of the lymphatic system in cholesterol transportEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesMetabolic syndrome, diabetes, and cardiovascular risk in HIVThe roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolismInsights into the Tunnel Mechanism of Cholesteryl Ester Transfer Protein through All-atom Molecular Dynamics SimulationsStructural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferaseNutritional lipidomics: molecular metabolism, analytics, and diagnosticsHow anacetrapib inhibits the activity of the cholesteryl ester transfer protein? Perspective through atomistic simulationsAn XML-based system for synthesis of data from disparate databasesStructural features of cholesteryl ester transfer protein: a molecular dynamics simulation studyStructural basis of transfer between lipoproteins by cholesteryl ester transfer protein.Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure.Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux.Expansion of the Bactericidal/Permeability Increasing-like (BPI-like) protein locus in cattleDalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in ratsCholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Effects of fluvastatin on plasma levels of low-density lipoprotein subfractions, oxidized low-density lipoprotein, and soluble adhesion molecules: a twenty-four-week, open-label, dose-increasing studyAnalysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis.Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and ELow-density lipoprotein particle size in hepatic steatosis and metabolic syndromeDalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeysTransgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).Study of Cholesteryl Ester Transfer Protein (CETP) I405v Genotype and Its Association with Lipid Fractions in Myocardial Infarction Patients: A Case Control Study.Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population.Lipid exchange mechanism of the cholesteryl ester transfer protein clarified by atomistic and coarse-grained simulationsAssociation between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.microRNAs and HDL life cycle.Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructureXanthohumol prevents atherosclerosis by reducing arterial cholesterol content via CETP and apolipoprotein E in CETP-transgenic mice.Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Atomistic MD simulation reveals the mechanism by which CETP penetrates into HDL enabling lipid transfer from HDL to CETP
P2860
Q24562095-825E26CA-2FBE-4B3B-97A0-6DC8AE317C0DQ24646308-635BF10D-72BA-45EA-AA0F-2BEDF9A52709Q24671906-F3252860-78BC-4F42-A4EA-ED3E6E20104BQ24673369-5BEDD6A4-08BE-483E-9B00-7401BE755832Q26753158-264DFE6A-D9E3-4775-8CB9-7E983CD33BC2Q26782973-32C8CABA-0B26-478E-BE81-E576E04264E7Q26825467-2F307695-EDFE-419C-BCBD-E30F91BC1C1DQ26853470-F254EA7E-32F5-4563-920A-25B943D73393Q27021950-1129741D-AA9D-43F0-A2F4-CC00423F42DFQ27312096-6DB05C84-3BAF-4962-B273-73284C2E44F3Q27626928-48569D71-F22F-4B5C-B161-568A625F93CDQ28390150-131EB236-4BE6-47B3-9592-3C65C2178DE2Q28545075-5DEB5138-DD46-4700-8FB8-A13757039FDFQ28768377-7B4276CA-5F8C-4C8B-8531-E397906F2057Q30155210-0B4265BA-E76E-439C-8AAA-22870CC28F19Q30155371-DF4FEEFF-F53C-4043-B04B-A45D4A28D45EQ30175288-6AF48D18-A34C-4A67-A215-47FC61F13244Q30436835-153E0329-0B10-437E-BB54-E4A5F40C851AQ30717581-F9DF7AEA-6CB8-4F14-BB03-66A636E19B9DQ33278833-3517E988-7F5E-4D61-97BE-97D4C8280A02Q33569541-00D75466-5BE4-46BD-9395-64F2E1F6756CQ33590777-72C9667D-C0B5-4816-9B90-59302A6193B0Q33738872-EE35E64C-8A2C-4457-B419-A852620B441FQ33741256-8D80F918-797B-437D-8C9C-89464870CF96Q33754249-CED9CC21-B3A7-45C4-87E6-D77286463D6FQ33811228-8C10709A-B0CB-45F5-812F-26CDAE9297ACQ33867662-EC8556C6-8874-4533-ACAF-496216F71303Q33910842-B257129C-293A-4329-BB77-B4511DC084CEQ34030331-420BE9C7-96A0-4A11-8927-90230B015CD1Q34062910-C3878C3C-7F56-4CAB-A2FB-3B76162461F2Q34130158-670EF4E0-BE6A-4310-BA1D-7C8F385EBE67Q34149298-449D50AF-B7F1-4DCA-A378-12B7DA1EE259Q34243501-05663AED-1A69-46C8-92D3-9AF8CD005C75Q34248289-A640E88E-C941-441B-B452-F3FE13FDEE71Q34253290-8A656F01-BB23-4563-8E4E-71F1E3A372CEQ34344559-291F529E-0508-4323-8189-441AF16AE6CFQ34482324-9EB0CE70-A863-4CAD-A9F9-FF912D8A9640Q34628218-F38D39AE-9083-467A-ACBD-32043053181EQ34651427-8E636B3F-CA1F-4335-9BD0-08A88A1362D5Q34757508-11298225-DCC3-47DA-8853-86C15961DA7A
P2860
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Plasma cholesteryl ester transfer protein.
@ast
Plasma cholesteryl ester transfer protein.
@en
Plasma cholesteryl ester transfer protein.
@nl
type
label
Plasma cholesteryl ester transfer protein.
@ast
Plasma cholesteryl ester transfer protein.
@en
Plasma cholesteryl ester transfer protein.
@nl
prefLabel
Plasma cholesteryl ester transfer protein.
@ast
Plasma cholesteryl ester transfer protein.
@en
Plasma cholesteryl ester transfer protein.
@nl
P1476
Plasma cholesteryl ester transfer protein.
@en
P2093
P304
P577
1993-08-01T00:00:00Z